# The Use of Methylene Blue in Pilonidal Sinus Surgery Reduces the Risk of Recurrence: A Systematic Review and Meta-Analysis

**Authors:** Matthias Maak, Christina Oetzmann von Sochaczewski, Theo Hackmann, Marcel Bonni, Myriam Braun-Münker, Dietrich Doll

PMC · DOI: 10.3390/medicina62020238 · 2026-01-23

## TL;DR

Using methylene blue during pilonidal sinus surgery may lower the chance of the condition coming back, according to a review of many studies.

## Contribution

This systematic review and meta-analysis shows methylene blue staining in surgery reduces recurrence rates across multiple surgical techniques.

## Key findings

- Methylene blue use significantly reduced recurrence rates in most surgical approaches for pilonidal sinus disease.
- The benefit of methylene blue was consistent across different surgical techniques like open approach and midline closure.
- However, methylene blue showed a disadvantage in some flap surgeries, though with limited follow-up data.

## Abstract

Background and Objectives: Pilonidal Sinus Disease shows an increasing incidence. Surgical interventions are often necessary; thus, we wanted to analyze whether the usage of methylene blue (MB) for staining the PSD fistulas for better visualization during surgery shows an effect concerning recurrence rates. Materials and Methods: A thorough data search and cross-study data synthesis of publications in the time period of 1833 to 2023 lead to a total of 7936 studies focusing on PSD. The data sets were scanned for the eligibility criteria, namely treatment information, follow-up, recurrence data, and the use of MB in surgery. The data were sorted into different surgical treatment groups, and the recurrence rates were analyzed using Kaplan–Meier-survival curves. Results: A total of 1192 studies involving 130,677 patients were eligible for analysis. A total of 263 studies were performed with MB (22.1%, n = 25,602 patients) and 929 studies without MB (77.9%, n = 105,075 patients). Overall, there was a highly significant difference in RR between the group of MB-stained patients and those without (p < 0.0001), even if analyzed separately for treatments. Primary open approach, primary midline closure, primary asymmetric closure, and Limberg/Dufourmentel all showed a significantly lower RR when MB was used (p < 0.0001). The use of MB in Bascom/Karydakis-Flap showed a statistically significant disadvantage concerning RR (p < 0.0001), and Other Flaps showed less RR with the use of MB (p = 0.011); both groups showed a notable loss of follow-up data, diminishing the meaning of these p values. Conclusions: This study shows that the use of MB as a staining technique in PSD surgery may be beneficial regarding recurrence rates. Therefore, the routinely use of MB staining in PSD surgery should be considered.

## Linked entities

- **Chemicals:** methylene blue (PubChem CID 4139)
- **Diseases:** pilonidal sinus disease (MONDO:0008249)

## Full-text entities

- **Diseases:** infected (MESH:D007239), methemoglobinemia (MESH:D008708), glucose-6-phosphate dehydrogenase (G6PD) deficiency (MESH:D005955), cyst (MESH:D003560), dermoid (MESH:D003884), fistula (MESH:D005402), PSD (MESH:C536311), neoplastic (MESH:D009369), pain (MESH:D010146), inflammatory skin conditions (MESH:D012871), injury to (MESH:D014947), serotonin syndrome (MESH:D020230), MB (MESH:D018329), PSD (MESH:D010864)
- **Chemicals:** hydrogen peroxide (MESH:D006861), Pilonidal (-), NaCl (MESH:D012965), Toluidine-blue (MESH:D014048), patent blue (MESH:C008769), MB (MESH:D008751)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941716/full.md

---
Source: https://tomesphere.com/paper/PMC12941716